Chinese President Xi Jinping and President Trump. Photo: Xinhua/Li Tao via Getty Images

A senior official from the State Council's Development Research Center is arguing that President Trump's trade war is part of a broader plan to contain China.

Driving the news: The U.S. is expected to impose tariffs on another $200 billion of Chinese imports as soon as next week, Bloomberg reported yesterday, with no denial from Trump.

The South China Morning Post summarized the commentary by Long Guoqiang:

“With the US labelling China as a strategic rival, Sino-US relations will experience a deep structural change,” he said. “As two major powers, it is normal for China and the US to engage in both cooperation and competition … We should abandon our illusions in facing the [trade] war, while at the same time remain rational and work hard to maintain overall stability.”..
Long’s commentary is the latest in a series of articles in People’s Daily over the last month apparently aimed at addressing growing scepticism over whether the Chinese economy will be able to weather the increasing pressure from Washington...
“China has changed from seeing this as primarily a trade conflict to now seeing it as part of a strategic competition,” said Wang Yong, director of the Centre for International Political Economy at Peking University. “So now China is preparing for a prolonged battle – and also for the worst-case scenario of a new cold war, or even a hot war.”

The bottom line: Both sides look to be preparing for a much more contentious relationship.

Go deeper: The coming yearlong U.S. trade war with China.

Go deeper

Updated 4 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 10 p.m. EST: 32,135,220 — Total deaths: 981,660 — Total recoveries: 22,149,441Map.
  2. U.S.: Total confirmed cases as of 10 p.m EST: 6,975,980 — Total deaths: 202,738 — Total recoveries: 2,710,183 — Total tests: 98,481,026Map.
  3. Politics: House Democrats prepare new $2.4 trillion coronavirus relief package.
  4. Health: Cases are surging again in 22 states — New York will conduct its own review of coronavirus vaccine.
  5. Business: America is closing out its strongest quarter of economic growth.
  6. Technology: 2020 tech solutions may be sapping our resolve to beat the pandemic.
  7. Sports: Pac-12 will play this fall despite ongoing pandemic — Here's what college basketball will look like this season.
  8. Science: Global coronavirus vaccine initiative launches without U.S. or China — During COVID-19 shutdown, a common sparrow changed its song.
7 hours ago - Sports

Pac-12 will play football this fall, reversing course

A view of Levi's Stadium during the 2019 Pac-12 Championship football game. Photo: Alika Jenner/Getty Images

The Pac-12, which includes universities in Arizona, California, Colorado, Oregon, Utah and Washington state, will play football starting Nov. 6, reversing its earlier decision to postpone the season because of the coronavirus pandemic.

Why it matters: The conference's about-face follows a similar move by the Big Ten last week and comes as President Trump has publicly pressured sports to resume despite the ongoing pandemic. The Pac-12 will play a seven-game conference football season, according to ESPN.

Dave Lawler, author of World
8 hours ago - World

Global coronavirus vaccine initiative launches without U.S. or China

Data: Gavi, The Vaccine Alliance; Map: Naema Ahmed/Axios

A global initiative to ensure equitable distribution of coronavirus vaccines now includes most of the world — but not the U.S., China or Russia.

Why it matters: Assuming one or more vaccines ultimately gain approval, there will be a period of months or even years in which supply lags far behind global demand. The COVAX initiative is an attempt to ensure doses go where they're most needed, rather than simply to countries that can produce or buy them at scale.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!